Drug Pipeline

Odevixibat Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Phase 3
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-29 NCT05426733
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in…		 date change Primary completion moved earlier: 2028-08-31 -> 2028-06-30
2026-05-29 NCT05426733
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in…		 date change Completion moved earlier: 2028-08-31 -> 2028-06-30
Active Studies by Phase
Phase 3
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05035030 Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome Alagille Syndrome Recruiting
NCT04336722 Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a… Biliary Atresia Active, Not Recruiting
NCT05426733 An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in… Biliary Atresia Enrolling by Invitation
Sponsors Running Odevixibat Trials
Albireo, an Ipsen Company (3)
Get alerts when Odevixibat trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free